ARCHIVES

Cancer Act Renewals Marked By Disputes Over NCI Authorities

This article is from The Cancer Letter archive.

Vol. 16 No. 38 | October 5, 1990

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says

February 12, 1999

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

May 11, 2012

Cancer Panel Statement On Access To Cancer Care.

October 6, 2000

James Doroshow Named NCI Deputy Director, Clinical Research

June 10, 2011

NCI Outlines Plan for Marin County Breast Cancer Review

November 22, 2002

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007